The UK's University of Oxford has partnered with Serum Institute of India Ltd., the world’s largest vaccine manufacturer by volume, to produce its COVID-19 vaccine ChAdOx1 nCoV-19, as it aims to make 100 million doses of the product available by December.
While privately-owned Serum Institute declined to provide additional information, CEO Adar Poonawalla spoke about a manufacturing tie-up with the university...






